KAYRINFA Trademark

Trademark Overview


On Wednesday, March 3, 2021, a trademark application was filed for KAYRINFA with the United States Patent and Trademark Office. The USPTO has given the KAYRINFA trademark a serial number of 90557474. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, May 13, 2024. This trademark is owned by Sanofi Pasteur Inc.. The KAYRINFA trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccine preparations
kayrinfa

General Information


Serial Number90557474
Word MarkKAYRINFA
Filing DateWednesday, March 3, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, May 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesHuman vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi Pasteur Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSwiftwater, PA 18370

Party NameSanofi Pasteur Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSwiftwater, PA 18370

Trademark Events


Event DateEvent Description
Saturday, March 6, 2021NEW APPLICATION ENTERED
Wednesday, June 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 25, 2021ASSIGNED TO EXAMINER
Saturday, September 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 5, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, October 1, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 9, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 9, 2022SOU EXTENSION 1 FILED
Thursday, June 9, 2022SOU EXTENSION 1 GRANTED
Saturday, December 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2022SOU EXTENSION 2 FILED
Thursday, December 15, 2022SOU EXTENSION 2 GRANTED
Monday, May 22, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 22, 2023SOU EXTENSION 3 FILED
Monday, May 22, 2023SOU EXTENSION 3 GRANTED
Monday, May 13, 2024SOU EXTENSION 5 FILED
Monday, May 13, 2024SOU TEAS EXTENSION RECEIVED
Monday, May 13, 2024SOU EXTENSION 5 GRANTED
Tuesday, May 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 6, 2023SOU EXTENSION 4 FILED
Wednesday, December 6, 2023SOU EXTENSION 4 GRANTED

Related Keywords


kayrinfa preparations vaccine human